Insurance Post’s Top 75 MGAs revealed
Markerstudy and Policy Expert have been the named the country’s two biggest MGAs after achieving revenues of between £80m and £100m for UK-based non-life risks in 2022.
How the Insurance Post Top 75 MGAs List 2023 was produced
Market analyst Insuramore reviewed revenues - defined as fees and commissions earned in relation to UK-based risks from any kind of direct non-life insurance - to produce Insurance Post's Top 75 MGAs List.
TOP 21 COMPANY LISTINGS
Top 75 MGAs 2023: Markerstudy
Top 75 MGAs: Policy Expert
Top 75 MGAs: Animal Friends
Top 75 MGAs: Arch Capital Group Ltd
Top 75 MGAs: Ardonagh
Top 75 MGAs: Gallagher
Top 75 MGAs: ICW Insurance Services
Top 75 MGAs: Many Group
Top 75 MGAs: Nexus Underwriting
Top 75 MGAs: AutoProtect
Top 75 MGAs: Avantia
Top 75 MGAs: CFC Underwriting
Top 75 MGAs: EGV Holdings
Top 75 MGAs: Howden Group
Top 75 MGAs: PIB Group
Top 75 MGAs: Brown & Brown
Top 75 MGAs: Countrywide Legal Indemnities
Top 75 MGAs: Prestige Underwriting
Top 75 MGAs: Ripe
Top 75 MGAs: Simply Business
Top 75 MGAs: Zego
BANDINGS
Top 75 MGAs 2023: £80m - £100m
Markerstudy and Policy Expert achieved MGA/MGU revenues between £80m and £100m from UK-based non-life risks in 2022 earning the companies top billing in Insurance Post's Top 75 MGAs 2023 list.
Top 75 MGAs 2023: £60m - £80m
Animal Friends, Arch Capital Group, Ardonagh Group, and Gallagher achieved MGA/MGU revenues between £60m and £80m from UK-based non-life risks in 2022.
Top 75 MGAs 2023: £40m - £60m
ICW Insurance Services, Many Group, and Nexus Underwriting achieved MGA/MGU revenues between £40m and £60m from UK-based non-life risks in 2022.
Top 75 MGAs 2023: £30m - £40m
AutoProtect, Avantia, CFC Group, EGV (Holdings), Howden Group Holdings, and PIB Group achieved MGA/MGU revenues between £30m and £40 from UK-based non-life risks in 2022.
Top 75 MGAs 2023: £20m - £30m
Brown & Brown, Countrywide Legal Indemnities, Prestige Underwriting, Ripe, Simply Business and Zego achieved MGA/MGU revenues between £20m and £30 from UK-based non-life risks in 2022.